Triaziquone

Triaziquone

SCHEMBL9644546

C[Si](C)(C)n1c(N)nc2[nH]cnc2c1=O.O=C1C=C(N2CC2)C(=O)C(N2CC2)=C1N1CC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10597939 0.81 PNP (0.33) —
Triaziquone SCHEMBL149876 0.69 MAPT (0.46) —
Triaziquone SCHEMBL2208738 0.67 MAPT (0.46) —
Triaziquone SCHEMBL588726 0.67 MAPT (0.46) —
Triaziquone SCHEMBL7117809 0.67 MAPT (0.44) —
Triaziquone SCHEMBL8303 0.67 DNMT1 (0.48) —
Triaziquone SCHEMBL8829051 0.67 MAPT (0.42) —
SCHEMBL2385669 0.66 PNP (0.34) —
Triaziquone SCHEMBL10906735 0.66 HTT (0.43) —
Triaziquone SCHEMBL11039269 0.66 MAPT (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0130126-B1 (S)-9-(2,3-DIHYDROXY-1-PROPOXYMETHYL) GUANINE AND ITS ACYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ANTIHERPETIC AGENTS MERCK & CO. INC. (US) 1987-08-26 — — EP claimed
EP-0272446-B1 NOVEL ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1992-11-11 — — EP disclosed
US-4360522-A VIRICIDES BURROUGHS WELLCOME CO. (US) 1982-11-23 — — US disclosed
US-4294831-A ANTIVIRAL ACTIVITY BURROUGHS WELLCOME CO. (US) 1981-10-13 — — US disclosed
US-4287188-A PARTICULARLY 9-(2-HYDROXYETHOXYMETHYL) GUANINE MONOPHOSPHATE AND SALTS, USEFUL AS ANTIVIRIAL AGENTS BURROUGHS WELLCOME CO. (US) 1981-09-01 — — US disclosed
US-4146715-A ANTIVIRAL AGENTS BURROUGHS WELLCOME CO. (US) 1979-03-27 — — US disclosed
Send feedback